How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?

[1] Rovirosa A.(2006)Uterine tumours with sarcomatous component. Past, present and future Oncologia 29 277-282

[2] Reed N.S.(2008)Phase III randomised study to evaluate the role of adjuvant radiotherapy in the treatment of uterine sarcomas stages I and II: a European organisation for research and treatment of cancer Gynaecological Cancer Group study (protocol 55874) Eur J Cancer 44 808-818

[3] Mangioni C.(2004)Surveillance, epidemiology and end results analysis of 2677 cases of uterine sarcoma 1989–1999 Gynecol Oncol 93 204-208

[4] Malmström H.(2002)Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages Int J Radiat Oncol Biol Phys 52 1320-1329

[5] Brooks S.E.(2004)Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma endometrioid type Histopathology 44 472-479

[6] Zhan M.(1998)Prognostic factors in uterine sarcomas: a retrospective study of 21 years at the Hospital Clínica i Provincial de Barcelona Med Clin (Barc) 111 172-176

[7] Coe T.(1989)Clinicopathologic analyses of uterine malignant mixed müllerian tumors Gynecol Oncol 34 372-378

[8] Baquet C.R.(1997)Uterine sarcomas: incidence and trends in man agement and survival Gynecol Oncol 65 158-163

[9] Rovirosa A.(1993)Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients Br J Radiol 66 1009-1015

[10] Ascaso C.(1996)Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 25-32

[1] Rovirosa A.(2006)Uterine tumours with sarcomatous component. Past, present and future Oncologia 29 277-282

[2] Reed N.S.(2008)Phase III randomised study to evaluate the role of adjuvant radiotherapy in the treatment of uterine sarcomas stages I and II: a European organisation for research and treatment of cancer Gynaecological Cancer Group study (protocol 55874) Eur J Cancer 44 808-818

[3] Mangioni C.(2004)Surveillance, epidemiology and end results analysis of 2677 cases of uterine sarcoma 1989–1999 Gynecol Oncol 93 204-208

[4] Malmström H.(2002)Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages Int J Radiat Oncol Biol Phys 52 1320-1329

[5] Brooks S.E.(2004)Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma endometrioid type Histopathology 44 472-479

[6] Zhan M.(1998)Prognostic factors in uterine sarcomas: a retrospective study of 21 years at the Hospital Clínica i Provincial de Barcelona Med Clin (Barc) 111 172-176

[7] Coe T.(1989)Clinicopathologic analyses of uterine malignant mixed müllerian tumors Gynecol Oncol 34 372-378

[8] Baquet C.R.(1997)Uterine sarcomas: incidence and trends in man agement and survival Gynecol Oncol 65 158-163

[9] Rovirosa A.(1993)Survival, patterns of spread and prognostic factors in uterine sarcoma: a study of 76 patients Br J Radiol 66 1009-1015

[10] Ascaso C.(1996)Uterine leiomyosarcoma: analysis of treatment failures and survival Gynecol Oncol 62 25-32